Jim Simons Aim Immuno Tech Inc. Transaction History
Renaissance Technologies LLC
- $56.7 Billion
- Q2 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Aim Immuno Tech Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 228,808 shares of AIM stock, worth $57,202. This represents 0.0% of its overall portfolio holdings.
Number of Shares
228,808
Previous 220,808
3.62%
Holding current value
$57,202
Previous $104,000
19.23%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding AIM
# of Institutions
37Shares Held
8.42MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY4.08MShares$1.02 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.99MShares$497,1760.0% of portfolio
-
Black Rock Inc. New York, NY698KShares$174,5660.0% of portfolio
-
Geode Capital Management, LLC Boston, MA401KShares$100,2560.0% of portfolio
-
State Street Corp Boston, MA173KShares$43,2750.0% of portfolio
About AIM ImmunoTech Inc.
- Ticker AIM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,049,300
- Market Cap $12M
- Description
- AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...